LungÕ 2026: Global Experts Examine the Changing Landscape of Lung Cancer Care
After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer
Solomon Moshkevich Named CEO of Natera
Timothy Rebbeck: Science Gains a Stronger Voice in the U.S. Congress
Prostate Cancer Radiotherapy: HYPO-RT-PC Study Reveals Significant Gaps Between Patient and Clinician Symptom Reporting
Can Laser Hair Removal Cause Cancer? What Science Says
SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia
OncoDaily Breast is OncoDaily’s dedicated platform for breast cancer, covering the rapidly evolving landscape of breast oncology. It focuses on the full spectrum of breast malignancies, including hormone receptor-positive/HER2-negative, HER2-positive, triple-negative, and other molecular subtypes. Through OncoDaily Breast, readers can follow the latest clinical trial developments, ongoing research, FDA and EMA approvals, guideline updates, emerging therapies, advances in biomarkers and precision oncology, major conference findings, and interviews with leading experts in breast cancer.
